Overview Drug Interaction Statin Status: Completed Trial end date: 2014-05-01 Target enrollment: Participant gender: Summary This purpose of this study is to assess the effects of BMS-919373 on the single dose Pharmacokinetics (PK) of Rosuvastatin and Atorvastatin in healthy subjects. Phase: Phase 1 Details Lead Sponsor: Bristol-Myers SquibbTreatments: AtorvastatinAtorvastatin CalciumRosuvastatin Calcium